Postoperative reduced dose of cisplatin concomitant with radiation therapy in high-risk head and neck squamous cell carcinoma

Cancer

Volumn 115, Issue 11, 2009, Pages 2464-2471

  Franchin, Giovanni ^a   Minatel, Emilio ^a   Politi, Doriano ^b   Gobitti, Carlo ^a   Talamini, Renato ^a   Vaccher, Emanuela ^a   Savignano, Maria Gabriella ^b   Trovo, Marco ^a   Sulfaro, Sandro ^b   Barzan, Luigi ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b General Hospital   (Italy)

Author keywords

Head and neck neoplasms; Low dose concomitant cisplatin; Postoperative radiotherapy; Squamous cell carcinoma

Indexed keywords

CISPLATIN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; CAUSE SPECIFIC SURVIVAL; CLINICAL TRIAL; DERMATITIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; POSTOPERATIVE PERIOD; RISK; SURVIVAL ANALYSIS;

EID: 66649134716     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24252     Document Type: Article

References (11)

1. Cooper JS, Pajak TF, Forestiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944. (Pubitemid 38580196)
2. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952. (Pubitemid 38580197)
3. Pindborg JJ, Reichart PA, Smith CJ, et al. Histological typing of cancer and precancer of the oral mucosa. 2nd ed.Berlin:Springer; 1997.
4. Franchin G, De Paoli A, Gobitti C, et al. Postoperative radiotherapy in locally advanced head and neck cancer. Tumori. 1989;75:47-52. (Pubitemid 19119890)
5. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:13-47. (Pubitemid 30179675)
6. Porceddu SV, Campbell B, Rischin D, et al. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2004;60:365-373. (Pubitemid 39233453)
7. Haffty BG, Son YH, Papac R, et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. J Clin Oncol. 1997;15:268-276. (Pubitemid 27020583)
8. Al-Sarraf M, Pajak TF, Byhardt RW, Beitler JJ, Salter MM, Cooper JS. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys. 1997;37:777-782. (Pubitemid 27181308)
9. Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999-1004. (Pubitemid 27014483)
10. Argiris A, Karamouzis MV, Johnson JT, et al. Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer. Laryngoscope. 2008;118:444-449.
11. Racadot S, Mercier M, Dussart S, et al. Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement. Radiother Oncol. 2008;87:164-172.